Put Options

2 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2019

Aug 08, 2019

SELL
$72.24 - $91.27 $2.39 Million - $3.02 Million
-33,100 Closed
0 $0
Q1 2019

May 06, 2019

BUY
$69.31 - $91.53 $2.29 Million - $3.03 Million
33,100 New
33,100 $98,000

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $11.1B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Nine Masts Capital LTD Portfolio

Follow Nine Masts Capital LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nine Masts Capital LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nine Masts Capital LTD with notifications on news.